The nascent channel peptide emerges from an exit port of the ribosomal tunnel. This tunnel begins at the inside and outside of the ribosome. A compact structure (likely helical) that corresponds to a region of PTC, located in a cavity at the interface between the large and small ribosomal subunits, and runs through helicity in the mature structure is already manifest in the nascent protein within the ribosomal tunnel. 
acid identity between T1 Kv1.2 and 1.3; Figures 1A and 1B). Three separate residue pairs (T69/Q112, Q72/G114, and R83/Q136) in Kv1.3 produce consistent estimates of P xlink , thereby supporting this assay as a reliable measure of folding (Kosolapov and Deutsch, 2003). All three full-length proteins are functional. T69/Q112 and Q72/ G114 are located between layers 1 and 2, and R83/Q136 is located between layers 1 and 3, according to the layer designations of Kreusch et al. (1998) . In this study, we used primarily Q72C/G114C, depicted in Figure 1B , in the folding assay.
Tertiary Structure Formation
A series of constructs was made in a cysteine-free Kv1.3 background that contained engineered cysteines 72C/ 114C in the T1 domain. The corresponding single cysteine constructs were also made and used as negative controls in the folding assays. All of these constructs were designed to generate biogenic peptide intermediates that remain attached to the ribosome (so-called "nascent" peptides). To do this, we made mRNA to Kv1.3 cDNA that had been truncated at selected restriction sites and therefore lacked a stop codon (Lu et al., 2001). As depicted in Figure 1C , this produces nascent Kv1.3 peptides with different linker lengths between the PTC and the C terminus of T1 and different emergent lengths of the T1 domain from the ribosomal tunnel. The BstEIIcut construct generates the longest nascent peptide, a total of 388 amino acids, with a linker length of 246 amino acids between the C terminus of T1 and the PTC. The NcoI-cut construct generates the shortest nascent peptide, a total of 142 amino acids, in which the C terminus is directly attached to the PTC (zero intervening amino acid linker length). The total number of amino acids and the number of intervening amino acids between the PTC and any given engineered cysteine (⌬PTC-Cys) are given in Table 1 for all constructs.
The folding assays were performed on all the constructs shown in Figure ( 72  70  80  101  104  129  316  83  59  69  90  93  118  305  112  30  40  61  64  89  276  114  28  38  59  62  87  274  116  26  36  57  60  85  272  1 3 6  6  1 6  3 7  4 0  6 5  2 5 2 The total amino acid length of each peptide is given by the number in parentheses under the name of each restriction site. The extent of labeling is the fraction of total peptide pegylated at Ն4 hr. Reactivity of each cysteine was determined by measuring the fraction of peptide modified by PDM (0.5 mM, 30 min; Supplemental peptide (e.g., EcoNI-cut) was released using RNase, amino acids away from the PTC and is maximal and then centrifuged, and the supernatant and pellet asconstant when this distance is Ն60 amino acids from the sayed for folding. We deliberately chose experimental PTC. This is true regardless of which pair of cysteines, conditions that generate a fraction still attached to the Q72C/G114C (Figure 3) or R83C/Q136C (data not ribosome, which will remain in the pellet, and a fraction shown), is used in the folding assay. Several negative released into the supernatant. In this case, we can dicontrols were used in these assays. First, similar length rectly compare folding of the released peptide to folding constructs containing a single cysteine (Q72C, R83C, of the unreleased peptide in the same sample. The re-G114C, or Q136C) were pegylated subsequent to PDM leased EconI-cut peptide folds in the supernatant (Figtreatment G114C has a rate that is too slow to measure (gel in Figure 5B ). These rates are consistent with the assigned locations outside versus inside the ribosome, respectively, for G114C/BstEII, Q72C/BstEII, and Q72C/NcoI versus G114C/NcoI. Relatively slower rates are consistent with cysteines being at a hindered location (Lu and Deutsch, 2001). In all cases, the final extent of labeling was achieved by 1-2 hr. To determine the final extent of labeling in all constructs from the shortest to the longest, for all cysteines, we performed replicate experiments using either a 4 hr and 6 hr point or a 4 hr and 20 hr point and 20 mM PEG-MAL to ensure maximum labeling in a reasonable time. This concentration of reagent is nonperturbing, as 19 mM free PEG (no attached MAL) in the presence of 1 To study the accessibility of a given cysteine in elonThe availability of a given cysteine depends on its locagated nascent Kv1.3 peptides, we used the restriction tion. For instance, the structure of the ribosome reveals sites shown in Table 1 and Figure 6A . For example, the a narrow exit tunnel extending the length of the large number of amino acids between the PTC and G114C is subunit, ‫001ف‬ Å from the PTC to the exit port ( Figure  28 , 38, 59, 62, 87, and 274 for NcoI, EcoN I, EarI, SacI, 5A). The width of the tunnel varies from ‫01ف‬ Å to a XbaI, and BstEII, respectively (also see Figure 1C ). With maximum of 20 Å near the exit port. PEG-MAL cannot increasing linker length (⌬PTC-G114C), the relative penetrate deeply into the tunnel, which is only freely amount of pegylation increases. As shown in Figure 6B , accessible to small molecules (see Figure 6B , below). significant modification (38% pegylated) of cysteine 114 Thus, both kinetics and final extent of pegylation of occurs after 38 amino acids have been synthesized besingle engineered cysteines should reflect relative actween the PTC and G114C and is completely accessible cessibility. We began by measuring the kinetics of modi-(Ն77%) when Ն62 amino acids have been synthesized fication of Q72C and G114C, engineered separately into between the PTC and G114C. This corresponds to a peptide in which all of the T1-S1 linker has been syntheboth NcoI and BstEII ( Figure 5B ). In the longer construct, sized and the T1 domain is completely out of the tunnel.
assay (e.g., G114C NcoI and EconI) show efficient PDM labeling (Supplemental Table S1 , F 1 and F 2 [http://www. In this case, the cysteines in each folding assay pair are in the same cytosolic compartment and thus capable neuron.org/cgi/content/full/44/2/295/DC1]; Table 1, see  Reactivity) . Thus, the reason for failure to crosslink is of folding (see Figure 3) . Q136C, near the PTC in the NcoI-cut construct, is relatively inaccessible ‫%03ف(‬ not due to a failure of the cysteines to either ionize or sterically accommodate PDM, but rather to a distance, pegylated) until it emerges at the distal end of the ribosomal exit tunnel and saturates at ‫%08ف‬ pegylation orientation, and/or flexibility limitation of the pair of cysteines. (Table 1) . Those cysteines that cannot be pegylated efficiently are still reactive, but are relatively inaccessible To confirm the relative inaccessibility in the region of G114C in the EconI-cut Kv1.3, we studied separately to PEG-MAL. This is shown in Figure 6B by the ‫%09ف‬ labeling for G114C by PDM, a small cysteine reagent Q112C and R116C (Table1), as well as two double cysteine constructs (see below). In the former case, pegylathat gets into the tunnel and has a fast reaction rate in an aqueous environment at 4ЊC (Ͼ500 M Ϫ1 s Ϫ1 , J.M. tion of the cysteines in the EcoNI-cut Kv1.3 was Յ26%, whereas pegylation of the same cysteines in the BstEIIRobinson and C.D., unpublished data). Note that those constructs that could not be crosslinked in the folding cut Kv1.3 was Ն81%. These results are similar to those To address this issue, we compared the fraction pegyHerein we describe the compartments in which struclated to the predicted pegylation for an extended conforture is acquired for a Kv channel domain. We draw two mation and an ␣ helix. Our data are consistent with major conclusions. First, the T1 domain acquires tertiary helix formation inside the ribosome. The following four structure only after emerging from the ribosomal exit experimental results support this conclusion. First, tunnel. Second, the T1 domain sequence already starts G114C in the EcoN I-cut nascent peptide is 38 amino to acquire a more compact, perhaps helical, structure acids from the PTC (Table1, Figure 6B) . If the peptide is while still inside the ribosomal tunnel. in an all-extended conformation, then the total distance spanned would be 129 Å and the cysteine would be Tertiary Structure outside the ribosome and available for pegylation. HowOur results show that the primary determinant of P xlink ever, it is only 38% pegylated, only 46% of its maximum is distance/orientation, which is dictated by the probalabeling efficiency (82% for BstEII-cut Kv1.3 nascent bility of tertiary folding of the peptide. Thus, a low P xlink peptide), suggesting that some compact structure must for short peptides and a higher P xlink for long peptides exist inside the ribosome. Second, G114C in EarI-cut represents unfolded and folded nascent peptide, renascent peptide is 62 amino acids from the PTC, prespectively. In the case of intermediate length nascent dicting a length of 211 Å for the all-extended conformapeptides, T1 is partially folded. Either some fraction of tion and complete pegylation. However, this cysteine is T1 is completely folded and the rest is completely unonly 53% pegylated. Third, two other residues in the folded, or 100% of T1 is partially folded. We cannot vicinity of G114C, Q112C and R116C in EcoN I-cut pepeasily distinguish between these possibilities. tide, are also pegylated Յ26% (Figure 6D ), whereas an To interpret the apparent length dependence of foldall-extended structure in this region predicts that these ing, we had to locate each cysteine of the engineered residues would be 136 and 122 Å , respectively, in length pair in each nascent peptide. This identifies the comand therefore easily accessible and pegylated. As with partment in which folding occurs. If the cysteines are in G114C EcoNI, the low pegylation is not due to decreased different compartments, then tertiary folding is prereactivity (Table1, Reactivity). Fourth, a R101C/D105C
cluded. If they are in the same compartment yet the construct in NcoI is only 19% pegylated, while it is 78% domain does not fold, then we might speculate that pegylated in the BstEII-cut construct (data not shown).
another factor is responsible. We therefore determined In the NcoI peptide, R101C and D105C are 41 and 37 the approximate compartment location of each cysteine amino acids away from the PTC, respectively, predicting using pegylation in an accessibility assay. We have predistances of 62 Å and 56 Å if the peptide is all helix viously validated the pegylation method to determine and 139 Å and 126 Å , respectively, if the peptide is allthe membrane topology of Kv1.3 (Lu and Deutsch, 2001) extended. In the BstEII peptide, 101C and 105C are 287 and refer the reader to this paper for a more comprehenand 283 residues away from the PTC, Ն400 Å regardless sive discussion of the advantages, disadvantages, and of the intervening secondary structure, and therefore caveats of this approach. always available for pegylation. These results demonThe pegylation assay depends on the availability of strate that a compact secondary structure exists within the SH group, its reactivity, and the stability of the PEG the ribosomal exit tunnel.
adduct. The latter parameter is not an issue because the maleimide-cysteine bond is a stable, covalent linkDiscussion age. Nor is reactivity, which is governed by the pKa of the cysteine and the local pH, as we measured reactivity How does a Kv channel acquire its secondary, tertiary, for each residue both inside and outside of the ribosome and quaternary structures? Given the polytopic and using a small molecular weight maleimide and found it oligomeric nature of ion channels, composed of many relatively invariant. Thus, differences in pegylation rebiogenic and functional domains (Tu et al., 2000) , this flect availability, most likely due to differences in steric question is quite complex. The answer will form the basis exclusion of PEG-MAL from the tunnel. for understanding normal biogenesis of ion channels as Pores and tunnels are conceptual cousins, each capawell as abnormal misfolding and attendant conseble of housing peptide segments. For example, the S4 quences for trafficking. Perturbations of biogenesis are segment of Kv channels likely traverses a short gating believed to underlie many inherited channelopathies, for pore and can be assessed by substituted cysteine acexample, those responsible for the majority of cases of cessibility measurements (Larsson et al., 1996; Yang cystic fibrosis and cardiac long QT syndrome (Ashcroft, et al., 1996) . Analogously, the peptide passenger of a 2000). Misfolding has been inferred mostly from ER loribosomal tunnel can be scrutinized by substituted cyscalization of the channel protein and/or decreased surteine accessibility measurements and pegylation, proface expression of the channel. However, folding can be viding a novel strategy to map the intra-versus extrarimore compellingly evaluated using assays specifically bosomal location of amino acids in a nascent peptide. designed for this purpose. The results shown in Figure 6 and Table 1 suggest Second, the detergents used in these studies may prethat segments within the T1 domain form a compact clude association of other proteins normally associated structure, likely an ␣ helix, inside the ribosomal tunnel. with the ribosome under native conditions in vivo. Thus, This conclusion is based on several residues (G114C in these dimensions of the ribosomal tunnel are anatomical EcoNI and in EarI; Q112C and R116C, each in EcoNI; dimensions of a stripped down ribosome complex. and R101C/D105C in NcoI) that are pegylated much less Recently obtained structures of the ribosome indicate than the amount predicted if they were in an all-extended another important consideration, namely that the riboconformation, and yet are pegylated Ͼ80% in the long somal exit tunnel is dynamic. One suggestion comes BstEII construct in which the cysteines are outside the from the crystal structure of the large subunit of the tunnel (all Ͼ380 Å regardless of the secondary conforribosome with bound macrolide antibiotic in the tunnel mation) and thus accessible. A change in G114C acces- (Berisio et al., 2003) . The macrolide induces a conformasibility from ‫52ف‬ to 80% requires 34 amino acids versus tional rearrangement of a tunnel wall component. Thus, only 6 amino acids for an all-extended control peptide our view of the ribosomal tunnel must include gating (J. Lu and C.D., unpublished data). This is consistent mechanisms and shape changes. The other evidence with a compact structure inside the ribosomal tunnel comes from a cryo-EM reconstruction of the ribosome for these regions of T1. These regions correspond to with nascent peptide trapped within the exit tunnel (Gil-␣3, ␣4, and ␣5 in the T1 crystal structure (see Figure  bert et al., 2004) . In this case, nascent peptide appears 1A). Thus, a compact structure is already manifest in the to displace the walls of the exit tunnel and increase the nascent protein inside the ribosome that corresponds to internal volume of the exit tunnel. The nascent peptide, a region of helicity in the mature structure. Whether the however, was not visualized well enough to discern any conformation inside the ribosome is strictly helical or detailed structure. A dynamic ribosome could uncramp some other form of compact structure cannot be deterthe tunnel enough to allow for tertiary folding. However, mined at this time. this does not appear to be the case in our study. AlCompaction of nascent peptide inside the ribosome though PDM can label cysteine pairs deep within the has been implicated previously from four types of ribosomal tunnel, it does not crosslink them. Only when assays: protease protection, enzymatic activity of nathese pairs emerge from the tunnel can they crosslink, scent proteins, antibody binding, and glycosylation indicative of a folded structure.
( . Protease ited tertiary folding inside the ribosome in the short pepprotection and enzymatic activity depend not only on tides (NcoI-and EcoNI-cut), i.e., cramped quarters, we emergent length of the peptide, but also on proper acdetermined the efficiency of folding for these peptides cess of the substrate to a correctly folded active site. released from the ribosome prior to the folding assay.
Glycosylation depends on an oligotransferase located From these studies, we draw two conclusions. First, in the lumen of the ER and thus the entire ribosome/ the short peptides are fully competent to form tertiary structures when released from the ribosome. Second, translocon complex is evaluated as a unit. The same caveats regarding substrate-active site interactions aly appears for 136C EarI vis-à -vis 114C EarI constructs apply in this case as well. In the case of antibody binding, (Table1), the latter having a lower extent of pegylation. a minimum chain length for the epitope to be exposed Two considerations account for this behavior. First, the and recognized is required and can be used to estimate reactivities of 136C versus 114C may be different. Secthe conformational state of the chain inside the riboond, the T1 crystal structure reveals that residues 136 some (Tsalkova et al., 1998) . There is some ambiguity, and 114 are in proximity due to a tertiary fold. The latter however, because an epitope must be correctly premay suggest that some folding of an intermediate length sented to be recognized by the antibody. Thus, tertiary chain occurs in the more distal, wider parts of the exit structure requirements may confound the apparent tunnel and may be compatible with a recent cryo-EM chain length required for emergence.
image ). This latter finding confers a may not be a general injunction at all, but rather a procaveat on the determination of secondary structure. Neitein-specific observation. Different proteins contain dother the accessibility measurements, the FRET measuremains of differing helix propensity. Indeed, it may be ments, nor any other measurements of emergent length the inherent helix propensity of the sequence that detercan distinguish between true helical structure and any mines whether compact structure forms in the riboother compact structure. At this time, we may only dissomal tunnel.
tinguish an extended structure from a compact strucAnother contrasting feature is the length of putative ture. Nonetheless, we can conclude that the T1 domain compact chain detected. Pegylation of residues G114C, of Kv channels acquires a compact structure inside the Q112C, and R116C in the EcoNI-cut T1 nascent peptide ribosome soon after it is synthesized and before it exits suggest that the segment residing inside the ribosome the ribosomal tunnel. Moreover, the nascent T1 domain is compact even though the total stretch of helix in the folds efficiently into its tertiary structure only after the mature T1 structure ( Figure 1A ) is too short according domain is outside of the tunnel and the T1-S1 linker has to Woolhead et al. to form a compact structure in the been completely synthesized. tunnel. This segment includes an 11 amino acid helix Channel assembly requires the acquisition of correct (␣4) and an 11 amino acid helix (␣5) separated by 3 quaternary, tertiary, and secondary structure. These amino acids. Yet, we still detect compact structure. Is events may be coupled and synchronous, one promotthis because the ribosome does not "see" the intervening the other (J.M. Robinson and C.D., unpublished ing 3 amino acids and effectively senses a 22 amino data). Similarly, association of auxiliary subunits with a acid stretch with high helix propensity? Alternatively, channel depends on folding and assembly of the chanWoolhead et al.'s prohibition may be protein specific.
nel subunits and may even facilitate these events (Shi et One final comment regarding residue 136 is waral., 1996). Failure to associate can lead to inappropriate ranted. In the NcoI-cut nascent peptide, 136C is only 6 targeting and/or function of the complex and to patholresidues away from the PTC and is pegylated 35%, ogy. These studies are aimed at understanding the steppresumably from the opening at the top of the tunnel wise progression of structure acquisition of ion chanat the interface between the small and large ribosome nels, and they pave the way for scrutiny of the remaining subunits ( Figure 5A ). This foyer is large enough to permit Kv domains. tRNA and antibiotics to enter and does not prevent PEG-MAL entry, although accessibility is somewhat limited.
Experimental Procedures
A longer chain (EcoN1) places 136C further into the constricted part of the tunnel, decreasing pegylation to Analysis of Pegylation Ladders Capped cRNA was synthesized in vitro from linearized templates For any given construct, radioactive protein incubated with PEGusing Sp6 RNA polymerase (Promega, Madison, WI). Linearized tem-MAL or PEG-SH was detected as distinct bands on NuPAGE gels plates for Kv1.3 translocation intermediates were generated using and quantified using PhosphorImaging. The data were analyzed as several restriction enzymes to produce different length DNA confollows. For each lane, j, of the gel, the fraction of total protein structs lacking a stop codon (see Figure 1C) well as those residing outside. Specifically, we compare the labeling Sigma Chemical Co.), 0.5 mM, was added to those samples to be in single cysteine constructs and double cysteine constructs and labeled while a control sample was treated identically but in the can estimate the crosslinking efficiency as follows. Consider a proabsence of PDM, at ‫0ف‬ЊC for 30 min. No reducing agent was present tein that has one of two different cysteines (A or B). For N ϭ 1, a single in these incubations. PDM samples used for subsequent MAL-pegycysteine construct with, for example, cysteine A, the probability that lation were quenched with 10 mM ␤-mercaptoethanol at room temit will be labeled by PEG-SH, F 3,A , is given by the following. perature for 10 min. Control samples, untreated with PDM, were treated identically. A third sample was labeled with PDM but re-F 3,A ϭ Pr{A has a free maleimide}P PEG-SH,A , (3) served for treatment with PEG-SH. Thiol reducing agents must be avoided in PDM samples subsequently treated with PEG-SH, otherwhere P PEG-SH,A is the probability that cysteine A labeled with PDM wise free maleimides will be modified and further assay with PEGreacts with PEG-SH. F 3,B is calculated similarly for cysteine B. F 3,A SH will be blocked. Samples were centrifuged at 70,000 rpm, 4ЊC, and F 3,B are determined, for example, from lane 3 of the gels in for 15 min, resuspended in 50 l PBS containing 1% SDS, and Figure 2 for Q72C and G114C, respectively, using Equations 1 and incubated at room temperature for 30 min. Those samples desig-2. The probability of labeling cysteine A in the double mutant connated for pegylation with methoxy-polyethylene glycol maleimide taining both cysteine A and cysteine B, P A,AB , is as follows. (PEG-MAL, MW 5000; Shearwater, Inc.) were treated with 10 mM ␤-mercaptoethanol to prevent oxidation, which inhibits pegylation. P A,AB ϭ (fraction of non-crosslinked cysteine A's Samples destined for pegylation with methoxy-polyethylene-thiol labeled by PEG-SH)(fraction of cysteine A not (PEG-SH, MW 5000; Shearwater, Inc.) received 50 l PBS containing crosslinked to cysteine B) ϭ F 3,A (1 Ϫ P xlinkA ), bility of a pair of cysteines being crosslinked by PDM is The rate constants for pegylation of selected T1 cysteines were determined as follows. Translation reaction (5-8 l) was diluted with 500 l PBS and centrifuged through a sucrose cushion at 70,000 P xlink ϭ 1 Ϫ (2F 3,AB )/(F 3,A ϩ F 3,B ).
Constructs and In Vitro Translation

28%. Further elongation increases the pegylation, with
